AtlantiCare Joins Registry to Improve Cardiogenic Shock Treatment

The American Heart Association, the world’s leading nonprofit organization focused on heart and brain health for all, has recognized AtlantiCare for participation in a new Cardiogenic Shock Registry to improve the quality of care and to better understand the clinical symptoms of shock types, treatment patterns and outcomes.

Cardiogenic shock — a life threatening condition when a person’s heart can’t pump enough blood to meet the needs of the body — is most often caused by serious heart attack or advanced heart failure. Historically, data related to cardiogenic shock has been limited, inconsistent and challenging to interpret. 

“We are pleased to recognize the leaders and teams at AtlantiCare for their strong commitment to caring for people with cardiogenic shock,” said David A. Morrow, MD, MPH, FAHA, FACC,co-chair of the American Heart Association’s Cardiogenic Shock Registry steering committee. “The data gathered by this registry is instrumental to improving the science community’s understanding of best practices for the treatment of patients with cardiogenic shock.”

Powered by Get With The Guidelines^®, the American Heart Association’s Cardiogenic Shock Registry gathers real-time data from acute care hospitals across the nation to provide a foundation for improving the quality and consistency of care in patients in U.S. hospitals with cardiogenic shock symptoms.

As a participant in the Cardiogenic Shock Registry, AtlantiCare has access to a robust web-based tool for tracking all patients hospitalized with cardiogenic shock. The tool features on-demand reporting and dashboards for responsive quality improvement. 

The Cardiogenic Shock Registry builds on more than 20 years of quality improvement and registry experience and will help inform the larger medical community on how to best treat cardiogenic shock.

National-level aggregated, deidentified data will be available to researchers through the American Heart Association’s Precision Medicine Platform, a secure cloud-computing platform to facilitate the research. The Precision Medicine Platform, powered by Amazon Web Services, is a central hub for the cardiovascular and stroke research community to access vast and diverse datasets and cloud-based workspaces that enable state-of-the-art, high-performance computing, analytics and collaboration to accelerate scientific discovery.

The American Heart Association’s Cardiogenic Shock Registry is made possible through the generous financial support of founding supporters Abbott and Getinge.

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.